Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Nuclear receptor ROR-gamma modulators discovered at Nuevolution

July 16, 2021

Enrollment opens in first-in-human study of VIB-1116 for rheumatic diseases

July 15, 2021

Carna reports phase I SAD data on BTK inhibitor AS-0871

July 13, 2021

Landos Biopharma patents new LANCL2 activators

July 9, 2021

SHR-1314 studied in phase II/III trial for active ankylosing spondylitis

July 5, 2021

LG Chem reports data from phase II CLUE study of LC-350189 in chronic gout

July 2, 2021

Histogen opens phase I/II study of HST-003 for regeneration of knee cartilage

July 1, 2021

LG Chem patents sphingosine 1-phosphate receptor 1 agonists

July 1, 2021

HZN-7734 enters phase II study for SLE

June 30, 2021

New TLR7/8/9 antagonists identified at Roche

June 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...